Immunoprotein Diagnostic Testing Industry: Oncology Testing Market to reach US$4,943 million by 2019
Immunoprotein Diagnostic Testing Market (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assayand Immunoprotein Electrophoresis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
The immunoprotein diagnostic testing is the procedure of diagnosing the concentration of immunoproteins in the body of a living organism. Immunoprotein is a protein, which has immunological abilities providing immunity against pathogenic substances or organisms. These proteins create the integrated body system of cells, tissues, organs, or cell products to neutralize antigens. These proteins also enable the detection of many diseases as they exhibit an abnormal rise in the blood concentration in the diseased state. When exposed to antigen, the levels of these proteins raise ten to hundred folds within one or two days. The application of these immunoproteins has changed their paradigm to rapid testing from microbial testing.
Browse the full Immunoprotein Diagnostic Testing Market Report at http://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html
The rise in the need for quick and accurate detection of the diseases coupled with the increasing demand for precautionary healthcare in emerging economies is the major driving force behind the growth in the global immunoprotein diagnostic testing industry. The powerful global network of distributors is another factor fueling the developing market. Apart from this, the technical advancement and the commoditization of products are also expected to drive the market in the coming years.
In contrast to this, the high cost of diagnosis and the deployed base of conventional ELISA test are the main hindrances limiting the growth of the global immunoprotein diagnostic testing industry. However, immunochromatography,...